CONCEPT

• Research type

  Research Study

• Full title

  Phase 1 study of use of 5% Carbogen in treatment of paediatric non-convulsive status epilepticus

• IRAS ID

  82124

• Contact name

  Rob Forsyth

• Eudract number

  2011-005318-12

• ISRCTN Number

  N/A

• Research summary

  This study proposes a phase I safety and tolerability study of inhaled 5% carbon dioxide/ 95% oxygen (5% Carbogen) in non-convulsive status epilepticus (NCSE) in children.

• REC name

  North East - Tyne & Wear South Research Ethics Committee

• REC reference

  12/NE/0005

• Date of REC Opinion

  13 Apr 2012

• REC opinion

  Further Information Favourable Opinion